The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...
Elderberry and zinc both support immune health, but what happens when you combine them? Learn how these supplements work together to strengthen immunity.
The "Dense Deposit Disease Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, 2025-2035" has been added to ...
Omeros Corporation OMER recently announced that the FDA approved its YARTEMLEA (narsoplimab-wuug) to treat hematopoietic stem ...
Pain represents the cardinal symptom of osteoarthritis, yet its intensity, quality, and impact vary dramatically among ...
Unlike clinical-grade stimulators that require medical supervision or invasive procedures, Pulsetto is positioned within the ...
Explore EMSense Massager, an at-home EMS foot therapy device combining electrical stimulation and heat for modern muscle ...
Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...
FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...